Evidence map›Paper›PMID 33917905›Full record

ArticleBiomolecules2021

Cluster Analysis of Medicinal Plants and Targets Based on Multipartite Network.

Namgil Lee, Hojin Yoo, Heejung Yang

Abstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Effect ofJournal of diabetes and metabolic disorders · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Namgil LeeDepartment of Information Statistics, Kangwon National University, Chuncheon 24341, Korea.
Hojin YooBionsight, Incorporated, Chuncheon 24341, Korea.
Heejung YangBionsight, Incorporated, Chuncheon 24341, Korea.ORCID 0000-0001-5986-9024

Funding

National Research Foundation of Korea 2017R1C1B5076912National Research Foundation of Korea 2021R1C1C1011857
6 · The paper itself

Abstract

Network-based methods for the analysis of drug-target interactions have gained attention and rely on the paradigm that a single drug can act on multiple targets rather than a single target. In this study, we have presented a novel approach to analyze the interactions between the chemicals in the medicinal plants and multiple targets based on the complex multipartite network of the medicinal plants, multi-chemicals, and multiple targets. The multipartite network was constructed via the conjunction of two relationships: chemicals in plants and the biological actions of those chemicals on the targets. In doing so, we introduced an index of the efficacy of chemicals in a plant on a protein target of interest, called target potency score (TPS). We showed that the analysis can identify specific chemical profiles from each group of plants, which can then be employed for discovering new alternative therapeutic agents. Furthermore, specific clusters of plants and chemicals acting on specific targets were retrieved using TPS that suggested potential drug candidates with high probability of clinical success. We expect that this approach may open a way to predict the biological functions of multi-chemicals and multi-plants on the targets of interest and enable repositioning of the plants and chemicals.

Indexed as

Neural Networks, Computer3-Oxo-5-alpha-Steroid 4-DehydrogenaseAlgorithmsCluster AnalysisDatabases, ChemicalPharmaceutical PreparationsPlants, MedicinalReceptors, Androgen3-Oxo-5-alpha-Steroid 4-DehydrogenasePharmaceutical PreparationsReceptors, Androgenmedicinal plantsmulti-chemicalsmultipartite networkmulti-targetsnetwork analysis

Identifiers

PMID33917905
PMCPMC8068312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.